Cargando…

Novel method for the high-throughput production of phosphorylation site-specific monoclonal antibodies

Threonine phosphorylation accounts for 10% of all phosphorylation sites compared with 0.05% for tyrosine and 90% for serine. Although monoclonal antibody generation for phospho-serine and -tyrosine proteins is progressing, there has been limited success regarding the production of monoclonal antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurosawa, Nobuyuki, Wakata, Yuka, Inobe, Tomonao, Kitamura, Haruki, Yoshioka, Megumi, Matsuzawa, Shun, Kishi, Yoshihiro, Isobe, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850396/
https://www.ncbi.nlm.nih.gov/pubmed/27125496
http://dx.doi.org/10.1038/srep25174
_version_ 1782429654983901184
author Kurosawa, Nobuyuki
Wakata, Yuka
Inobe, Tomonao
Kitamura, Haruki
Yoshioka, Megumi
Matsuzawa, Shun
Kishi, Yoshihiro
Isobe, Masaharu
author_facet Kurosawa, Nobuyuki
Wakata, Yuka
Inobe, Tomonao
Kitamura, Haruki
Yoshioka, Megumi
Matsuzawa, Shun
Kishi, Yoshihiro
Isobe, Masaharu
author_sort Kurosawa, Nobuyuki
collection PubMed
description Threonine phosphorylation accounts for 10% of all phosphorylation sites compared with 0.05% for tyrosine and 90% for serine. Although monoclonal antibody generation for phospho-serine and -tyrosine proteins is progressing, there has been limited success regarding the production of monoclonal antibodies against phospho-threonine proteins. We developed a novel strategy for generating phosphorylation site-specific monoclonal antibodies by cloning immunoglobulin genes from single plasma cells that were fixed, intracellularly stained with fluorescently labeled peptides and sorted without causing RNA degradation. Our high-throughput fluorescence activated cell sorting-based strategy, which targets abundant intracellular immunoglobulin as a tag for fluorescently labeled antigens, greatly increases the sensitivity and specificity of antigen-specific plasma cell isolation, enabling the high-efficiency production of monoclonal antibodies with desired antigen specificity. This approach yielded yet-undescribed guinea pig monoclonal antibodies against threonine 18-phosphorylated p53 and threonine 68-phosphorylated CHK2 with high affinity and specificity. Our method has the potential to allow the generation of monoclonal antibodies against a variety of phosphorylated proteins.
format Online
Article
Text
id pubmed-4850396
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48503962016-05-05 Novel method for the high-throughput production of phosphorylation site-specific monoclonal antibodies Kurosawa, Nobuyuki Wakata, Yuka Inobe, Tomonao Kitamura, Haruki Yoshioka, Megumi Matsuzawa, Shun Kishi, Yoshihiro Isobe, Masaharu Sci Rep Article Threonine phosphorylation accounts for 10% of all phosphorylation sites compared with 0.05% for tyrosine and 90% for serine. Although monoclonal antibody generation for phospho-serine and -tyrosine proteins is progressing, there has been limited success regarding the production of monoclonal antibodies against phospho-threonine proteins. We developed a novel strategy for generating phosphorylation site-specific monoclonal antibodies by cloning immunoglobulin genes from single plasma cells that were fixed, intracellularly stained with fluorescently labeled peptides and sorted without causing RNA degradation. Our high-throughput fluorescence activated cell sorting-based strategy, which targets abundant intracellular immunoglobulin as a tag for fluorescently labeled antigens, greatly increases the sensitivity and specificity of antigen-specific plasma cell isolation, enabling the high-efficiency production of monoclonal antibodies with desired antigen specificity. This approach yielded yet-undescribed guinea pig monoclonal antibodies against threonine 18-phosphorylated p53 and threonine 68-phosphorylated CHK2 with high affinity and specificity. Our method has the potential to allow the generation of monoclonal antibodies against a variety of phosphorylated proteins. Nature Publishing Group 2016-04-29 /pmc/articles/PMC4850396/ /pubmed/27125496 http://dx.doi.org/10.1038/srep25174 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Kurosawa, Nobuyuki
Wakata, Yuka
Inobe, Tomonao
Kitamura, Haruki
Yoshioka, Megumi
Matsuzawa, Shun
Kishi, Yoshihiro
Isobe, Masaharu
Novel method for the high-throughput production of phosphorylation site-specific monoclonal antibodies
title Novel method for the high-throughput production of phosphorylation site-specific monoclonal antibodies
title_full Novel method for the high-throughput production of phosphorylation site-specific monoclonal antibodies
title_fullStr Novel method for the high-throughput production of phosphorylation site-specific monoclonal antibodies
title_full_unstemmed Novel method for the high-throughput production of phosphorylation site-specific monoclonal antibodies
title_short Novel method for the high-throughput production of phosphorylation site-specific monoclonal antibodies
title_sort novel method for the high-throughput production of phosphorylation site-specific monoclonal antibodies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850396/
https://www.ncbi.nlm.nih.gov/pubmed/27125496
http://dx.doi.org/10.1038/srep25174
work_keys_str_mv AT kurosawanobuyuki novelmethodforthehighthroughputproductionofphosphorylationsitespecificmonoclonalantibodies
AT wakatayuka novelmethodforthehighthroughputproductionofphosphorylationsitespecificmonoclonalantibodies
AT inobetomonao novelmethodforthehighthroughputproductionofphosphorylationsitespecificmonoclonalantibodies
AT kitamuraharuki novelmethodforthehighthroughputproductionofphosphorylationsitespecificmonoclonalantibodies
AT yoshiokamegumi novelmethodforthehighthroughputproductionofphosphorylationsitespecificmonoclonalantibodies
AT matsuzawashun novelmethodforthehighthroughputproductionofphosphorylationsitespecificmonoclonalantibodies
AT kishiyoshihiro novelmethodforthehighthroughputproductionofphosphorylationsitespecificmonoclonalantibodies
AT isobemasaharu novelmethodforthehighthroughputproductionofphosphorylationsitespecificmonoclonalantibodies